On October 31, 2011, President Obama signed an Executive Order directing the FDA to take action to help further prevent and reduce prescription drug shortages, protect consumers, and prevent price gouging. The President’s order directs FDA to broaden reporting of potential shortages of certain prescription drugs and to further expedite regulatory reviews that can help prevent or respond to shortages. Under this policy, FDA also will work with the Department of Justice, which will examine whether potential shortages have led to illegal price gouging or stockpiling of life-saving medications. The FDA has compiled information about its actions to address drug shortages.
- How-to guide How-to guide: How to protect your company from violations of the United States Foreign Corrupt Practices Act (USA)
- How-to guide How-to guide: Understanding the role and responsibilities of a nominated officer under the Money Laundering Regulations (UK)
- Checklist Checklist: Delivery and acceptance of goods in a business-to-business sale of goods contract (USA)